Josje Janna Otten
6PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 12, 2025
"Super-Responders" to Dupilumab Treatment in Patients With Primary Diffuse Chronic Rhinosinusitis With Nasal Polyps.P E Vonk, J J Otten, H B E Elzinga
|May 16, 2025
Two-Year Data of Tapered Dupilumab Shows High Effectiveness in Chronic Rhinosinusitis with Nasal Polyps With Nonsteroidal Anti-inflammatory Drug-Exacerbated Respiratory Disease.H B E Elzinga, J J Otten, M E Cornet
|Feb 06, 2025
Almost Half of the Dupilumab-Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year.Josje J Otten, Hester E Elzinga, Rik J L van der Lans
|Nov 26, 2024
Olfactory Dysfunction in Chronic Rhinosinusitis with Nasal Polyps: Effect of Treatment with Emphasis on Biological Therapy.Josje Janna Otten, Wytske Johanna Fokkens, Sietze Reitsma
|Oct 29, 2024
More than half of chronic rhinosinusitis with nasal polyps (CRSwNP) patients treated with dupilumab experience early and fast olfactory improvement within 28 days.Josje Janna Otten, Rik Johannes Leonardus van der Lans, Hester Beatrice Emilie Elzinga
|Jul 03, 2023
Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months.Rik Johannes Leonardus van der Lans, Josje Janna Otten, Gwijde Flavius Jacobus Petrus Maria Adriaensen
Pageof 1
Frequent Collaborators
5 joint publications
Sietze Reitsma
4 joint publications
Wytske Johanna Fokkens
3 joint publications
Hester E Elzinga
2 joint publications
Rik Johannes Leonardus van der Lans
1 joint publications
Gwijde Flavius Jacobus Petrus Maria Adriaensen
1 joint publications
Dinand Rienk Hoven
1 joint publications
Linda Berendina Benoist
